Vaxess Technologies
Vaxess engineers novel technologies that uniquely engage the human immune system, enabling improved efficacy and simplified access for vaccines and therapeutics.

Year Established: 2011
Stock Ticker:
Exchange:
Vaxess engineers novel technologies that uniquely engage the human immune system, enabling improved efficacy and simplified access for vaccines and therapeutics.
Vaxess Technologies is developing the MIMIX sustained release patch technology, that uses the unique qualities of silk proteins and breakthrough immune activating biology to enable best-in-class vaccines and therapeutics.
Vaxess Technologies is developing the MIMIX sustained release patch technology, that uses the unique qualities of silk proteins and breakthrough immune activating biology to enable best-in-class vaccines and therapeutics.
Vaxess engineers novel technologies that uniquely engage the human immune system, enabling improved efficacy and simplified access for vaccines and therapeutics.